FINWIRES · TerminalLIVE
FINWIRES

Top Midday Stories: Goldman Shares Fall Despite Q1 Earnings Topping Estimates; Revolution's Pancreatic Cancer Drug Met Key Study Goals

-- The Dow Jones Industrial Average was down while the S&P 500 and Nasdaq Composite were up in late-morning trading Monday, as Wall Street digests news from the weekend that the US and Iran failed to strike a deal, and President Donald Trump announced a blockade of the Strait of Hormuz.

In company news, Goldman Sachs (GS) reported Q1 earnings Monday of $17.55 per diluted share, up from $14.12 a year earlier and above the FactSet consensus analyst estimate of $16.47. First-quarter net revenue was $17.23 billion, up from $15.06 billion a year ago and above the FactSet consensus of $16.99 billion. The company also said it's launching a three-tranche, investment-grade bond offering in the US, with bond maturities spanning four to eight years, Bloomberg reported, citing a person with direct knowledge of the matter. Goldman shares were down 3.6% around midday.

Revolution Medicines (RVMD) said Monday the phase 3 trial of its experimental drug, daraxonrasib, intended to treat a type of pancreatic cancer, met key goals. The drug delivered a median overall survival of 13.2 months, compared with 6.7 months for chemotherapy, the company said. Revolution said it plans to submit the data to global regulators, including the US Food and Drug Administration, for marketing application. Revolution shares were up 36.4%.

GFL Environmental (GFL) has entered into a definitive agreement to acquire all of the issued and outstanding shares of Secure Waste Infrastructure for 24.75 Canadian dollars per share, representing an enterprise value of about CA$6.4 billion ($4.62 billion), the companies said Monday. The deal is expected to close in H2, they said. GFL shares were down 7.8%.

Fastenal (FAST) reported Q1 earnings Monday of $0.30 per diluted share, up from $0.26 a year earlier and in-line with the FactSet consensus. First-quarter net sales were $2.20 billion, up from $1.96 billion a year ago and in-line with expectations. Fastenal shares were down 6.7%.

Conagra Brands (CAG) said Monday it has appointed John Brase as chief executive officer and president, effective June 1. Brase, who previously served as chief operating officer and president at J.M. Smucker (SJM), will succeed Sean Connolly, who will step away from his leadership positions and board seat on May 31, the company said. Conagra shares were down 5.6%, while J.M. Smucker shares were down 2.7%.

Microsoft (MSFT) is developing new features for Copilot it hopes will make the AI assistant function more like OpenClaw, The Information reported Monday, citing a company statement. Microsoft shares were up 2.3%.

Price: $874.99, Change: $-32.81, Percent Change: -3.61%

相关文章

Australia

午盘涨幅最大的股票

德州仪器 (TXN) 周三晚间公布了第一季度盈利和营收增长,并发布了高于市场预期的第二季度业绩指引。 受此消息提振,德州仪器股价上涨 19%,盘中交易量从日均约 740 万股飙升至超过 1700 万股。 联合租赁 (URI) 隔夜公布了第一季度调整后盈利和营收增长,并上调了 2026 年销售额指引。 受此消息提振,德州仪器股价上涨 21%,盘中交易量从日均约 65.6 万股攀升至超过 92.55 万股。 西部制药服务公司 (WST) 周四公布了第一季度非 GAAP 盈利和净销售额增长。该公司还发布了高于分析师预期的第二季度业绩展望,并上调了 2026 年业绩指引。 受此消息提振,德州仪器股价上涨 12%,盘中交易量从日均约 94.4 万股跃升至超过 147 万股。Price: $281.28, Change: $+44.97, Percent Change: +19.03%

$TXN$URI$WST
Australia

Grace Therapeutics收到FDA关于GTx-104的完整回复函

Grace Therapeutics (GRCE) 表示,美国食品药品监督管理局 (FDA) 已就其新药申请 GTx-104(一种用于治疗动脉瘤性蛛网膜下腔出血的尼莫地平静脉制剂)发出完整回复函。 Grace 周四在一份声明中表示,FDA 指出申请文件中化学、生产和控制以及非临床部分存在一些未解决的问题,这些问题可以通过重新提交来解决。该公司表示,FDA 没有要求提供额外的临床数据。 Grace 表示,计划与 FDA 召开 A 类会议,以确定下一步措施。Price: $4.29, Change: $-0.02, Percent Change: -0.46%

$GRCE
Sectors

行业动态:能源

周四下午,能源股走高,纽约证券交易所能源板块指数上涨0.5%,道富能源精选板块SPDR ETF(XLE)上涨0.7%。 费城石油服务板块指数上涨1.6%,道琼斯美国公用事业指数上涨2.4%。 近月西德克萨斯中质原油期货价格上涨3.8%,至每桶96.49美元;全球基准布伦特原油期货价格上涨3.4%,至每桶105.41美元。亨利枢纽天然气期货价格下跌5.1%,至每百万英热单位2.58美元。 公司新闻方面,英国石油公司(BP)股东否决了一项旨在取消部分气候相关信息披露要求的提案,这些要求此前已获得投资者在股东大会上的投票支持。据媒体周四报道,阿尔伯特·曼尼福德以81.8%的得票率当选董事长。BP股价下跌0.6%。

$BP